Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Oaknin A, Bosse TJ, Creutzberg CL, et al. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(9):860–77.

Article  CAS  PubMed  Google Scholar 

De Felice F, Marchetti C, Tombolini V, Panici PB. Immune check-point in endometrial cancer. Int J Clin Oncol. 2019;24(8):910–6.

Article  PubMed  Google Scholar 

Onstad MA, Schmandt RE, Lu KH. Addressing the role of obesity in Endometrial Cancer Risk, Prevention, and treatment. J Clin Oncol. 2016;34(35):4225–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gong TT, Li D, Wu QJ, Wang YZ. Cholesterol consumption and risk of endometrial cancer: a systematic review and dose-response meta-analysis of observational studies. Oncotarget. 2016;7(13):16996–7008.

Article  PubMed  PubMed Central  Google Scholar 

Biel RK, Csizmadi I, Cook LS, Courneya KS, Magliocco AM, Friedenreich CM. Risk of endometrial cancer in relation to individual nutrients from diet and supplements. Public Health Nutr. 2011;14(11):1948–60.

Article  PubMed  Google Scholar 

Miettinen TA. Cholesterol production in obesity. Circulation. 1971;44(5):842–50.

Article  CAS  PubMed  Google Scholar 

Mc Auley MT. Effects of obesity on cholesterol metabolism and its implications for healthy ageing. Nutr Res Rev. 2020;33(1):121–33.

Article  PubMed  Google Scholar 

Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89(6):2583–9.

Article  CAS  PubMed  Google Scholar 

Feingold KR. Obesity and dyslipidemia. [Updated 2023 Jun 19]. In: Feingold KR, Anawalt B, Blackman MR, et al. editors. Endotext [Internet]. South Dartmouth (MA). MDText.com, Inc.; 2000-.

Franssen R, Monajemi H, Stroes ES, Kastelein JJ. Obesity and dyslipidemia. Med Clin North Am. 2011;95(5):893–902.

Article  CAS  PubMed  Google Scholar 

Karuna R, Holleboom AG, Motazacker MM, et al. Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism. Atherosclerosis. 2011;214(2):448–55.

Article  CAS  PubMed  Google Scholar 

DuSell CD, Umetani M, Shaul PW, Mangelsdorf DJ, McDonnell DP. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. Mol Endocrinol. 2008;22(1):65–77.

Article  CAS  PubMed  Google Scholar 

Gibson DA, Collins F, Cousins FL, Esnal Zufiaurre A, Saunders PTK. The impact of 27-hydroxycholesterol on endometrial cancer proliferation. Endocr Relat Cancer. 2018;25(4):381–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdalkareem Jasim S, Kzar HH, Haider Hamad M, et al. The emerging role of 27-hydroxycholesterol in cancer development and progression: an update. Int Immunopharmacol. 2022;110:109074.

Article  CAS  PubMed  Google Scholar 

Starkey NJE, Li Y, Drenkhahn-Weinaug SK, Liu J, Lubahn DB. 27-Hydroxycholesterol is an estrogen receptor β-Selective negative allosteric modifier of 17β-Estradiol binding. Endocrinology. 2018;159(5):1972–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Z, Martin KO, Javitt NB, Chiang JY. Structure and functions of human oxysterol 7alpha-hydroxylase cDNAs and gene CYP7B1. J Lipid Res. 1999;40(12):2195–203.

Article  CAS  PubMed  Google Scholar 

Nelson ER, Wardell SE, Jasper JS, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science. 2013;342(6162):1094–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Q, Ishikawa T, Sirianni R, et al. 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. Cell Rep. 2013;5(3):637–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He S, Ma L, Baek AE, et al. Host CYP27A1 expression is essential for ovarian cancer progression. Endocr Relat Cancer. 2019;26(7):659–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang P, Yuan D, Zhang C, et al. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort. Cardiovasc Diabetol. 2022;21(1):46.

Article  PubMed  PubMed Central  Google Scholar 

Rodriguez AC, Blanchard Z, Maurer KA, Gertz J. Estrogen Signaling in Endometrial Cancer: a key oncogenic pathway with several open questions. Horm Cancer. 2019;10(2–3):51–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carlson MJ, Thiel KW, Leslie KK. Past, present, and future of hormonal therapy in recurrent endometrial cancer. Int J Womens Health. 2014;6:429–35.

PubMed  PubMed Central  Google Scholar 

Chlebowski RT, Anderson GL, Sarto GE et al. Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women’s Health Initiative Randomized Trial. J Natl Cancer Inst 2016;108(3).

Dallal CM, Lacey JV Jr., Pfeiffer RM, et al. Estrogen Metabolism and risk of postmenopausal endometrial and ovarian Cancer: the B ∼ FIT cohort. Horm Cancer. 2016;7(1):49–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi SZ, Lee EJ, Lin YJ, et al. Recruitment of monocytes and epigenetic silencing of intratumoral CYP7B1 primarily contribute to the accumulation of 27-hydroxycholesterol in breast cancer. Am J Cancer Res. 2019;9(10):2194–208.

CAS  PubMed  PubMed Central  Google Scholar 

Tan X, Liu S, Yao L, Cui G, Liu J, Ding J. Comprehensive Analysis of a novel lipid metabolism-related gene signature for Predicting the Prognosis and Immune Landscape in Uterine Corpus Endometrial Carcinoma. J Oncol. 2022;2022:8028825.

Article  PubMed  PubMed Central  Google Scholar 

Le Cornet C, Walter B, Sookthai D, et al. Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort. Breast Cancer Res. 2020;22(1):23.

Article  PubMed  PubMed Central  Google Scholar 

Burkard I, von Eckardstein A, Waeber G, Vollenweider P, Rentsch KM. Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers. Atherosclerosis. 2007;194(1):71–8.

Article  PubMed  Google Scholar 

Kimbung S, Chang CY, Bendahl PO, et al. Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer. Endocr Relat Cancer. 2017;24(7):339–49.

Article  CAS  PubMed  Google Scholar 

Raza S, Meyer M, Goodyear C, Hammer KDP, Guo B, Ghribi O. The cholesterol metabolite 27-hydroxycholesterol stimulates cell proliferation via ERβ in prostate cancer cells. Cancer Cell Int. 2017;17:52.

Article  PubMed  PubMed Central  Google Scholar 

Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2004;13(10):1558–68.

Article  CAS  PubMed